Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial

Cancer

Volumn 122, Issue 2, 2016, Pages 312-321

  Green, Beverly B ^a,b,c   Anderson, Melissa L ^b   Chubak, Jessica ^b,d   Fuller, Sharon ^b   Meenan, Richard T ^e   Vernon, Sally W ^f  

^a Group Health Permanente   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d University of Washington School of Public Health   (United States)

^e CENTER FOR HEALTH RESEARCH   (United States)

^f UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

colonoscopy; colorectal cancer screening; complete diagnostic evaluation; navigation

Indexed keywords

AGE; AGED; CLINICAL TRIAL; COLORECTAL NEOPLASMS; CONTROLLED STUDY; EARLY CANCER DIAGNOSIS; FECES; FEMALE; FOLLOW UP; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; OCCULT BLOOD; PATIENT CARE; PATIENT COMPLIANCE; POSTAL MAIL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REMINDER SYSTEM; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNITED STATES;

AGE FACTORS; AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PATIENT-CENTERED CARE; POSTAL SERVICE; REMINDER SYSTEMS; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 84954075089     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29734     Document Type: Article

References (26)

1. Siegel RL, Miller KD, Jemal A., Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29.
2. Vogelaar I, van Ballegooijen M, Schrag D, et al., How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer. 2006; 107: 1624-1633.
3. US Preventive Services Task Force. Colorectal cancer: screening. http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm. Accessed March 19, 2015.
4. Roetzheim RG, Christman LK, Jacobsen PB, Schroeder J, Abdulla R, Hunter S., Long-term results from a randomized controlled trial to increase cancer screening among attendees of community health centers. Ann Fam Med. 2005; 3: 109-114.
5. Baker DW, Brown T, Buchanan DR, et al., Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014; 174: 1235-1241.
6. Meenan RT, Anderson ML, Chubak J, et al., An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015; 48: 714-721.
7. Green BB, Wang CY, Anderson ML, et al., An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013; 158 (5 pt 1): 301-311.
8. Green BB, Wang CY, Horner K, et al., Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010; 31: 589-603.
9. Green BB, Bogart A, Chubak J, et al., Nonparticipation in a population-based trial to increase colorectal cancer screening. Am J Prev Med. 2012; 42: 390-397.
10. Murphy CC, Verson SW, Haddock NM, Anderson ML, Chubak J, Green BB., Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014; 66: 123-130.
11. Reid RJ, Coleman K, Johnson EA, et al., The Group Health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff (Millwood). 2010; 29: 835-843.
12. Green BB, Anderson ML, Wang CY, et al., Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014; 27: 789-795.
13. Rand Corporation. Medical Outcomes Study: 36-Item Short Form Survey Instrument. RAND 36-Item Health Survey 1.0 Questionnaire Items. http://www.rand.org/health/surveys-tools/mos/mos-core-36item-survey.html. Accessed February 19, 2015.
14. McQueen A, Bartholomew LK, Greisinger AJ, et al., Behind closed doors: physician-patient discussions about colorectal cancer screening. J Gen Intern Med. 2009; 24: 1228-1235.
15. Laiyemo AO, Adebogun AO, Doubeni CA, et al., Influence of provider discussion and specific recommendation on colorectal cancer screening uptake among U.S. adults. Prev Med. 2014; 67: 1-5.
16. Shaukat A, Mongin SJ, Geisser MS, et al., Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013; 369: 1106-1114.
17. Mandel JS, Church TR, Bond JH, et al., The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343: 1603-1607.
18. Thomas W, White CM, Mah J, Geisser MS, Church TR, Mandel JS., Longitudinal compliance with annual screening for fecal occult blood. Minnesota Colon Cancer Control Study. Am J Epidemiol. 1995; 142: 176-182.
19. Steele RJ, McClements PL, Libby G, Carey FA, Fraser CG., Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer. Colorectal Dis. 2014; 16: 28-32.
20. Kapidzic A, Grobbee EJ, Hol L, et al., Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol. 2014; 109: 1257-1264.
21. National Committee for Quality Assurance. Improving Quality and Patient Experience-The State of Health Care Quality 2013. http://www.ncqa.org/Portals/0/Newsroom/SOHC/2013/SOHC-web-version-report.pdf. Accessed March 22, 2015.
22. Chubak J, Bogart A, Fuller S, Laing SS, Green BB., Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med. 2013; 57: 671-678.
23. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C., Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut. 2015; 64: 282-291.
24. Fenton JJ, Elmore JG, Buist DS, Reid RJ, Tancredi DJ, Baldwin LM., Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med. 2010; 8: 397-401.
25. Liss DT, Petit-Homme A, Feinglass J, Buchanan DR, Baker DW., Adherence to repeat fecal occult blood testing in an urban community health center network. J Community Health. 2013; 38: 829-833.
26. Duncan A, Turnbull D, Wilson C, et al., Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study. BMC Public Health. 2014; 14: 238.